Cipla reports 32 percent increase in net profit to Rs 1056 crore in Q3
Cipla MD and Global CEO Umang Vohra said the company's topline growth for the quarter was 14 per cent year-on-year.;
Advertisement
Bengaluru: Drug major Cipla has reported a 32 percent increase in consolidated net profit at Rs 1,056 crore for the December quarter, on the back of robust sales across geographies.
The Mumbai-based company had posted a consolidated net profit of Rs 801 crore in the year-ago period, Cipla Ltd said in a statement.
Total revenue from operations in the third quarter of the current fiscal rose to Rs 6,604 crore as compared with Rs 5,810 crore in the year-ago period.
Cipla MD and Global CEO Umang Vohra said the company's topline growth for the quarter was 14 per cent year-on-year.
The company's One India business grew at a healthy 12 per cent year-on-year backed by a strong performance across branded prescription, trade generics and consumer health, he noted.
"In North America, we continue to scale newer peaks by posting highest-ever quarterly revenue yet again at USD 230 million, supported by positive traction in key assets and base business," Vohra said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.